Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Medicina (B Aires) ; 58(4): 415-8, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9816705

RESUMO

SKF525A, an inhibitor and inducer of cytochrome P450, was tested on different developmental stages of Trypanosoma cruzi. Growth, motility and structure of epimastigotes, motility and infectivity of trypomastigotes, and infectivity of trypomastigotes to Vero cells in culture were abolished by the drug at 10-100 microM concentrations. When blood from infected mice was treated with the drug, and used to infect 8 day-old mice, no parasites were observed at 0.6-1 mM, and all animals survived. Blood cell morphology was well preserved, and the sleeping time of pentobarbital-treated mice inoculated with the same amount of drug was not increased. The present results suggest that SKF525A or other related inhibitors of cytochrome P450 coned be tested as an additive for blood sterilization in blood banks.


Assuntos
Inibidores Enzimáticos/farmacologia , Proadifeno/farmacologia , Tripanossomicidas/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Animais , Células Cultivadas , Chlorocebus aethiops , Sistema Enzimático do Citocromo P-450/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Pentobarbital/farmacologia , Fatores de Tempo , Trypanosoma cruzi/enzimologia , Trypanosoma cruzi/ultraestrutura , Células Vero/efeitos dos fármacos
2.
FEMS Microbiol Lett ; 124(1): 81-6, 1994 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-8001773

RESUMO

Three proteinase inhibitors, one peptidyl acyloxymethyl ketone (AMK), Z-Phe-Lys-CH2-OCO-(2,4,6-Me3)Ph.HCl, and two diazomethyl ketones (DMKs), Z-Phe-Phe-DMK and Z-Phe-Ala-DMK, have been studied for their effects in vitro on the four developmental stages of Trypanosoma cruzi. The three inhibitors penetrated living parasites and inhibited the major cysteine proteinase, cruzipain. The AMK was the most potent inhibitor of cruzipain itself and at 20 microM caused lysis of epimastigotes and trypomastigotes. When at lower concentrations, however, it had little effect on epimastigote growth but reduced metacyclogenesis. The DMKs had no effect against epimastigotes but inhibited differentiation to metacyclics. All three inhibitors markedly reduced infection of Vero cells by the parasite and the multiplication of the intracellular amastigotes, whereas release of trypomastigotes was almost entirely prevented. The results confirm the importance of cysteine proteinases in the life cycle of T. cruzi, and suggest that the differentiation steps are the most susceptible to cysteine proteinase inhibitors.


Assuntos
Inibidores de Cisteína Proteinase/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Animais , Chlorocebus aethiops , Cisteína Endopeptidases/metabolismo , Diazometano/análogos & derivados , Diazometano/farmacologia , Dipeptídeos/farmacologia , Cetonas/farmacologia , Proteínas de Protozoários , Trypanosoma cruzi/crescimento & desenvolvimento , Trypanosoma cruzi/patogenicidade , Células Vero/parasitologia
3.
Experientia ; 47(6): 612-6, 1991 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-1829686

RESUMO

The tricyclic anti-calmodulin drug trifluoperazine (TFP) inhibited growth and motility of epimastigotes of Trypanosoma cruzi, at concentrations lower than 100 microM, and motility and infectivity of the bloodstream trypomastigote form at 200 microM. Electron microscopy of TFP-treated epimastigotes showed that the major effect was at the mitochondrial level, with gross swelling and disorganization. The oligomycin-sensitive, mitochondrial ATPase was completely inhibited by 20 microM TFP, and the same drug concentration caused a 60% decrease in intracellular ATP content. The results suggest that the trypanocidal effect of TFP may be related more to mitochondrial damage than to the well-known anticalmodulin effect of the drug.


Assuntos
Mitocôndrias/efeitos dos fármacos , Trifluoperazina/farmacologia , Tripanossomicidas/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Adenosina Trifosfatases/antagonistas & inibidores , Trifosfato de Adenosina/metabolismo , Animais , Microscopia Eletrônica , Mitocôndrias/fisiologia , Dilatação Mitocondrial/efeitos dos fármacos , Oligomicinas/farmacologia , Trypanosoma cruzi/fisiologia , Trypanosoma cruzi/ultraestrutura
4.
Biochim Biophys Acta ; 1037(2): 186-91, 1990 Feb 09.
Artigo em Inglês | MEDLINE | ID: mdl-2407295

RESUMO

A cysteine proteinase, purified to homogeneity from epimastigotes of Trypanosoma cruzi, was strongly inhibited by L-trans-epoxysuccinylleucylamido(4-guanidino)butane (E-64). The second-order rate constant was 20,800 M-1.s-1, and the reagent could be used for active site titration. The enzyme hydrolysed chromogenic peptides at the carboxyl Arg or Lys; it required at least one more amino acid, preferably Arg, Phe, Val or Leu, between the terminal Arg or Lys and the amino-blocking group. Enzyme activity on azocasein at pH 5.0 was increased by urea, maximal activity being attained at 2 M, and was still as active at 5 M urea as in its absence. Guanidine hydrochloride and KSCN also activated at low concentrations, but caused a strong inhibition above 2 M and 1 M, respectively. When azocasein was tested as a substrate at pH 7.0, there was no activation, and when synthetic substrates were used all chaotropic agents tested were inhibitory. The results suggest that the enzyme, for which we propose the trivial name 'cruzipain', differs in some aspects from all other cysteine proteinases described so far, although it shares several of the properties of mammalian cathepsin L.


Assuntos
Cisteína Endopeptidases/isolamento & purificação , Trypanosoma cruzi/enzimologia , Sequência de Aminoácidos , Animais , Sítios de Ligação , Caseínas/metabolismo , Compostos Cromogênicos/metabolismo , Cisteína Endopeptidases/metabolismo , Inibidores de Cisteína Proteinase/farmacologia , Ativação Enzimática/efeitos dos fármacos , Concentração de Íons de Hidrogênio , Cinética , Leucina/análogos & derivados , Leucina/farmacologia , Dados de Sequência Molecular , Proteínas de Protozoários , Especificidade por Substrato
5.
FEMS Microbiol Lett ; 50(3): 259-63, 1989 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2668108

RESUMO

The pyruvate kinase from Trypanosoma cruzi epimastigotes was activated by fructose 2,6-diphosphate ((A) 0.5 = 0.17 microM), through a decrease in (S) 0.5 and an increase in Vmax for both substrates. The enzyme was 50% inhibited by 0.9 mM ATP or 0.5 mM Pi in the presence of 30 mM MgCl2; these inhibitions were completely counteracted by 1.5 microM fructose 2,6-diphosphate. Both facts suggest that the effects are allosteric, and not due to chelation.


Assuntos
Piruvato Quinase/metabolismo , Trypanosoma cruzi/enzimologia , Trifosfato de Adenosina/farmacologia , Animais , Ativação Enzimática/efeitos dos fármacos , Frutosedifosfatos/farmacologia , Cinética , Fosfatos/farmacologia , Piruvato Quinase/antagonistas & inibidores , Trypanosoma cruzi/crescimento & desenvolvimento
6.
Experientia ; 44(10): 880-1, 1988 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-3053234

RESUMO

Epimastigotes of Trypanosoma cruzi (Tulahuen strain Tul 0 stock) biotransform benznidazole (N-benzyl-2-nitro-1-imidazole acetamide) to reactive metabolites that bind covalently to DNA, proteins and lipids of the parasite. These effects might be related to the trypanocidal action of benznidazole, a chemotherapeutic agent against Chagas' disease.


Assuntos
DNA/metabolismo , Metabolismo dos Lipídeos , Nitroimidazóis/metabolismo , Proteínas/metabolismo , Trypanosoma cruzi/análise , Animais , Núcleo Celular/análise
7.
Mol Biochem Parasitol ; 26(1-2): 1-10, 1987 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-3323902

RESUMO

Axenic culture amastigote-like forms of Trypanosoma cruzi, grown at 28 degrees C, reach a stationary phase after two generations, and differentiate to epimastigotes, which then resume growth. Axenic culture amastigotes readily ferment glucose to succinate and acetate, and do not excrete NH3; they have high activities of hexokinase and phosphoenolpyruvate carboxykinase, and very low citrate synthase activity; cytochrome o is absent, and cytochrome b-like is present at a very low level. Epimastigotes catabolize glucose and produce succinate and acetate at a considerably lower rate; they exhibit lower levels of hexokinase and carboxykinase, and much higher levels of citrate synthase and cytochromes o and b-like. They catabolize amino acids, as shown by excretion of NH3 to the medium. The results suggest that axenic culture amastigotes have an essentially glycolytic metabolism, and they acquire the ability to oxidize substrates such as amino acids only after differentiation to epimastigotes.


Assuntos
Glucose/metabolismo , Trypanosoma cruzi/metabolismo , Aminoácidos/metabolismo , Animais , Metabolismo dos Carboidratos , Fermentação , Concentração de Íons de Hidrogênio , Oxirredução , Trypanosoma cruzi/crescimento & desenvolvimento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA